foto vaccino

The ChAdOx1 anti-COVID vaccine, developed by Oxford University's Jenner Institute with the collaboration of Italy's companies, "induced a strong immune and anti-body response up to the 56th day of the ongoing testing," the Lancet reported Monday.

These are the preliminary results of phase 1-2 of testing which involved 1,077 healthy adults. "Further studies are necessary to confirm if the vaccine effectively protects from COVID-19", the article said. 

"More time and patience is needed. But the first scientific results of the Oxford University vaccine, whose viral vector is made in Pomezia and will be placed in phials at Anagni, are encouraging," said Health Minister Roberto Speranza.

"Italy, with Germany, France and the Netherlands," he added, "is in the lead group for this testing. We are continuing to invest in scientific research as a key to defeat the virus".  The positive results of the anti-COVID vaccine tests  performed in Oxford is "good news" for the World Health Organization (WHO) too, according to the agency's health emergencies director Michael Ryan.

Source: Ansa

Consulta le notizie di Nuovo coronavirus,  le notizie di Vaccinazioni

Vai all' archivio completo delle notizie


Consulta l'area tematica: Nuovo coronavirusVaccinazioni

  • Condividi
  • Stampa
  • Condividi via email

Data di pubblicazione: 21 luglio 2020, ultimo aggiornamento 21 luglio 2020

Documentazione

Opuscoli e Poster